| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |